Frazier Management LLC Iveric Bio, Inc. Transaction History

Frazier Management LLC

  • $0
  • Q3 2022

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$12.15 - $16.83 $22.3 Million - $30.9 Million
-1,838,402 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$7.07 - $17.5 $4.99 Million - $12.4 Million
-706,098 Reduced 27.75%
1,838,402 $29.9 Million
Q1 2021

May 12, 2021
BUY
$5.08 - $6.89 $254,000 - $344,500
50,000 Added 2.0%
2,544,500 $15.7 Million
Q4 2020

Feb 11, 2021
BUY
$5.65 - $7.66 $734,500 - $995,800
130,000 Added 5.5%
2,494,500 $17.2 Million
Q2 2020

Aug 04, 2020
BUY
$3.06 - $6.6 $7.24 Million - $15.6 Million
2,364,500 New
2,364,500 $12.1 Million

Others Institutions Holding ISEE

# of Institutions
7
Shares Held
250K
Call Options Held
40K
Put Options Held
0
View Full List

About IVERIC bio, Inc.

ISEE Quotes by TradingView
  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Frazier Management LLC Portfolio

Follow Frazier Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frazier Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email